Corrigendum to: Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments

Login or register to view PDF.
Creative Commons Licence
 
Received date
18 December 2019
Accepted date
18 December 2019
DOI
https://doi.org/10.15420/ecr.2019.14.3.CG1
Open access
This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.

In the article by Juan Tamargo entitled Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments (European Cardiology Review 2019;14(1):23–32. https://doi.org/10.15420/ecr.2018.34.2), the following correction should be made:

Figure 1 should indicate an increase () in haemoglobin and haematocrit, not a decrease (). The corrected figure appears below.

The author apologises for this error.

Potential Mechanisms Involved in the Cardioprotective and Renoprotective Effects

Open in new tab